Atlanta Business Chronicle -- Theragenics Corp.’s profit dipped about 4 percent after moving costs in the third quarter.
The Buford, Ga.-based surgical products and cancer treatments company (NYSE: TGX) had net income of $771,000 and earnings of 2 cents a share, compared with net income of $799,000 and earnings of 2 cents a share in the third quarter of 2009.
During the third quarter of 2010, Theragenics spent $944,000 on its new specialty needle manufacturing facility and a corporate-wide information technology initiative. The company wrapped up construction of new facility in the third quarter. Moving related expenses were $433,000.
Third-quarter revenue grew about 6 percent to $20.4 million.
